The Stable Nitroxide Tempol Facilitates Salivary Gland Protection during Head and Neck Irradiation in a Mouse Model

Clinical Cancer Research

Volumn 10, Issue 5, 2004, Pages 1807-1812

  Vitolo, Joseph M ^a   Cotrim, Ana P ^a   Sowers, Anastasia L ^b   Russo, Angelo ^b   Wellner, Robert B ^a   Pillemer, Stanley R ^a   Mitchell, James B ^b   Baum, Bruce J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROXIDE; RADIOPROTECTIVE AGENT; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEAD AND NECK CANCER; MORBIDITY; MOUSE; MOUTH; NONHUMAN; NOSE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EQUIPMENT; RADIATION PROTECTION; SALIVA; SALIVARY GLAND; SALIVATION;

ANIMALS; ANTIOXIDANTS; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; FEMALE; HEAD AND NECK NEOPLASMS; MICE; MICE, INBRED C3H; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; SALIVARY GLANDS; SPIN LABELS;

EID: 1842428592     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0194     Document Type: Article

References (48)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA-Cancer J. Clin., 51: 15-36, 2001.
2. Vissink, A., Jansma, J., Spijkervet, F. K., Burlage, F. R., and Coppes, R. P. Oral sequelae of head and neck radiotherapy. Crit. Rev. Oral Biol. Med., 14: 199-212, 2003.
3. Vissink, A., Burlage, F. R., Spijkervet, F. K., Jansma, J., and Coppes, R. P. Prevention and treatment of the consequences of head and neck radiotherapy. Crit. Rev. Oral Biol. Med., 14: 213-225, 2003.
4. Nagler, R. M., and Baum, B. J. Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch. Otolaryngol. Head Neck Surg., 129: 247-250, 2003.
5. Eisbruch, A., Kim, H. M., Terrell, J. E., Marsh, L. H., Dawson, L. A., and Ship, J. A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 50: 695-704, 2001.
6. Eisbruch, A., Ship, J. A., Dawson, L. A., Kim, H. M., Bradford, C. R., Terrell, J. E., Chepeha, D. B., Teknos, T. N., Hogikyan, N. D., Anzai, Y., Marsh, L. H., Ten Haken, R. K., and Wolf, G. T. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J. Surg., 27: 832-837, 2003.
7. Koch, K. E., Roberts, J. C., and Lubec, G. Radiation protection by α-methyl-homocysteine thiolactone in vitro. Life Sci., 60: 341-350, 1997.
8. Frydrych, A. M., Davies, G. R., Slack-Smith, L. M., and Heywood, J. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia. Aust. Dent. J., 47: 249-253, 2002.
9. Sodicoff, M., Conger, A. D., Trepper, P., and Pratt, N. E. Short-term radioprotective effects of WR-2721 on the rat parotid glands. Radiat. Res., 75: 317-326, 1978.
10. Menard, T. W., Izutsu, K. T., Ensign, W. Y., Keller, P. J., Morton, T. H., and Truelove, E. L. Radioprotection by WR-2721 of γ-irradiated rat parotid gland: effect on gland weight and secretion at 8-10 days post irradiation. Int. J. Radiat. Oncol. Biol. Phys., 10: 1555-1559, 1984.
11. Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., and Sauer, R. Phase III randomized trial of amifostine as a radioprotector in heac and neck cancer. J. Clin. Oncol., 18: 3339-3345, 2000.
12. Hahn, S. M., Tochner, Z., Krishna, C. M., Glass, J., Wilson, L. Samuni, A., Sprague, M., Venzon, D., Glatstein, E., and Mitchell, J. B. Tempol, a stable free radical, is a novel murine radiation protector Cancer Res., 52: 1750-1753, 1992.
13. Mitchell, J. B., DeGraff, W., Kaufman, D., Krishna, M. C., Samuni, A., Finkelstein, E., Ahn, M. S., Hahn, S. M., Gamson, J., and Russo, A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch. Biochem. Biophys., 289: 62-70, 1991.
14. Mitchell, J. B., Russo, A., Kuppusamy, P., and Krishna, M. C. Radiation, radicals, and images. Ann. N. Y. Acad. Sci., 899: 28-43, 2000.
15. Xavier, S., Yamada, K., Samuni, A. M., Samuni, A., DeGraff, W., Krishna, M. C., and Mitchell, J. B. Differential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim. Biophys. Acta, 1573: 109-120, 2002.
16. Krishna, M. C., Grahame, D. A., Samuni, A., Mitchell, J. B., and Russo, A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. USA, 89: 5537-5541, 1992.
17. Koukourakis, M. I. Amifostine in clinical oncology: current use and future applications. Anti-Cancer Drugs, 13: 181-209, 2002.
18. Cairnie, A. B. Adverse effects of radioprotector WR2721. Radiat. Res., 94: 221-226, 1983.
19. Hahn, S. M., Sullivan, F. J., DeLuca, A. M., Krishna, C. M., Wersto, N., Venzon, D., Russo, A., and Mitchell, J. B. Evaluation of tempol radioprotection in a murine tumor model. Free Radic. Biol. Med., 22: 1211-1216, 1997.
20. Nagler, R. M., Baum, B. J., and Fox, P. C. Effects of X irradiation on the function of rat salivary glands at 3 and 40 days. Radiat. Res., 136: 392-396, 1993.
21. Nagler, R. M., Baum, B. J., and Fox, P. C. A 2 week pair-fed study of early X-irradiation effects on rat major salivary gland function. Arch. Oral Biol., 41: 713-717, 1996.
22. Nagler, R. M., Baum, B. J., and Fox, P. C. Acute effects of X irradiation on the function of rat salivary glands. Radiat. Res., 136: 42-47, 1993.
23. Nagler, R. M., Baum, B. J., Miller, G., and Fox, P. C. Long-term salivary effects of single-dose head and neck irradiation in the rat. Arch. Oral Biol., 43: 297-303, 1998.
24. Yamano, S., Atkinson, J. C., Baum, B. J., and Fox, P. C. Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin. Immunol. (Orlando), 92: 265-275, 1999.
25. Hahn, S. M., Wilson, L., Krishna, C. M., Liebmann, J., DeGraff, W., Gamson, J., Samuni, A., Venzon, D., and Mitchell, J. B. Identification of nitroxide radioprotectors. Radiat. Res., 132: 87-93, 1992.
26. Mitchell, J. B., Samuni, A., Krishna, M. C., DeGraff, W. G., Ahn, M. S., Samuni, U., and Russo, A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry, 29: 2802-2807, 1990.
27. Vissink, A., Kalicharan, D., S-Gravenmade, E. J., Jongebloed, W. L., Ligeon, E. E., Nieuwenhuis, P., and Konings, A. W. Acute irradiation effects on morphology and function of rat submandibular glands. J. Oral Pathol. Med., 20: 449-456, 1991.
28. Lin, A. L., Johnson, D. A., Wu, Y., Wong, G., Ebersole, J. L., and Yeh, C. K. Measuring short-term γ-irradiation effects on mouse salivary gland function using a new saliva collection device. Arch. Oral Biol., 46: 1085-1089, 2001.
29. Takeda, I., Kizu, Y., Yoshitaka, O., Saito, I., and Yamane, G. Y. Possible role of nitric oxide in radiation-induced salivary gland dysfunction. Radiat. Res., 159: 465-470, 2003.
30. Paardekooper, G. M., Cammelli, S., Zeilstra, L. J., Coppes, R. P., and Konings, A. W. Radiation-induced apoptosis in relation to acute impairment of rat salivary gland function. Int. J. Radiat. Biol., 73: 641-648, 1998.
31. O'Connell, A. C., Redman, R. S., Evans, R. L., and Ambudkar, I. S. Radiation-induced progressive decrease in fluid secretion in rat submandibular glands is related to decreased acinar volume and not impaired calcium signaling. Radiat. Res., 151: 150-158, 1999.
32. Zeilstra, L. J., Vissink, A., Konings, A. W., and Coppes, R. P. Radiation induced cell loss in rat submandibular gland and its relation to gland function. Int. J. Radiat. Biol., 76: 419-429, 2000.
33. Takagi, K., Yamaguchi, K., Sakurai, T., Asari, T., Hashimoto, K., and Terakawa, S. Secretion of saliva in X-irradiated rat submandibular glands. Radiat. Res., 159: 351-360, 2003.
34. Coppes, R. P., Zeilstra, L. J., Vissink, A., and Konings, A. W. Sialogogue-related radioprotection of salivary gland function: the degranulation concept revisited. Radiat. Res., 148: 240-247, 1997.
35. Sodicoff, M., Conger, A. D., Pratt, N. E., and Trepper, P. Radioprotection by WR-2721 against long-term chronic damage to the rat parotid gland. Radiat. Res., 76: 172-179, 1978.
36. Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., and Kolesnick, R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (Wash. DC), 293: 293-297, 2001.
37. Turner, R. J., and Sugiya, H. Understanding salivary fluid and protein secretion. Oral Dis., 8: 3-11, 2002.
38. Vitolo, J. M., and Baum, B. J. The use of gene transfer for the protection and repair of salivary glands. Oral Dis., 8: 183-191, 2002.
39. von Sonntag, C. The Chemical Basis of Radiation Biology. Taylor & Francis, 1987.
40. Samuni, A., Krishna, C. M., Riesz, P., Finkelstein, E., and Russo, A. A novel metal-free low molecular weight superoxide dismutase mimic. J. Biol. Chem., 263: 17921-17924, 1988.
41. Hirose, K., Longo, D. L., Oppenheim, J. J., and Matsushima, K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J., 7: 361-368, 1993.
42. Epperly, M. W., Gretton, J. E., Sikora, C. A., Jefferson, M., Bernarding, M., Nie, S., and Greenberger, J. S. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat. Res., 160: 568-578, 2003.
43. Yuhas, J. M., and Storer, J. B. Differential chemoprotection of normal and malignant tissues. J. Natl. Cancer. Inst. (Bethesda), 42: 331-335, 1969.
44. Yuhas, J. M., Spellman, J. M., and Culo, F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin. Trials, 3: 211-216, 1980.
45. Yuhas, J. M. Efficacy testing of WR-2721 in Great Britain: everything is black and white at the gray lab. Int. J. Radiat. Oncol. Biol. Phys., 9: 595-598, 1983.
46. Stewart, F. A., Rojas, A., and Denekamp, J. Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatments. Int. J. Radiat. Oncol. Biol. Phys., 9: 507-513, 1983.
47. Brizel, D. M., and Overgaard, J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol., 4: 378-381, 2003.
48. Cuscela, D., Coffin, D., Lupton, G. P., Cook, J. A., Krishna, M. C., Bonner, R. F., and Mitchell, J. B. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer J. Sci. Am., 2: 273, 1996.